Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | EYA2 | O00167 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | ACE | P12821 | 1/20 | 0.33 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.32 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3076946 | 0.92 | HDAC6 (0.38) | CA14HDAC6HDAC1HDAC2HDAC3 | |
| Glycine SCHEMBL28774225 | 0.92 | GLRA1 (0.39) | CA14HDAC6HDAC1HDAC2HDAC3 | |
| SCHEMBL4918504 | 0.92 | CA14 (0.37) | CA14HDAC6HDAC1HDAC2HDAC3 | |
| SCHEMBL16280777 | 0.91 | CA14 (0.39) | CA14HDAC6HDAC1HDAC2HDAC3 | |
| SCHEMBL2579003 | 0.91 | CA14 (0.42) | CA14HDAC6HDAC1HDAC2HDAC3 | |
| SCHEMBL11895925 | 0.90 | CA14 (0.36) | CA14HDAC6HDAC1HDAC2HDAC3 | |
| SCHEMBL4956364 | 0.90 | CA14 (0.36) | CA14HDAC6HDAC1HDAC2HDAC3 | |
| SCHEMBL1253034 | 0.90 | CA14 (0.38) | CA14HDAC6HDAC1HDAC2HDAC3 | |
| SCHEMBL3734491 | 0.89 | CA14 (0.39) | CA14HDAC6HDAC1HDAC2HDAC3 | |
| SCHEMBL19357464 | 0.89 | CA14 (0.36) | CA14HDAC6HDAC1HDAC2HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 443 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| US-20020048774-A1 | Liquid phase parallel synthesis of chemical libraries | BRISTOL-MYERS SQUIBB PHARMA RESEARCH LABS, INC. | 2002-04-25 | — | — | US | claimed |
| EP-0774464-A2 | A template for solution phase synthesis of combinatorial libraries | Combichem, Inc. (US) | 1997-05-21 | — | — | EP | claimed |
| US-20260108618-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2026-04-23 | — | — | US | disclosed |
| US-12569565-B2 | Compositions and methods for the treatment of viral infections | CIDARA THERAPEUTICS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-20260001924-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | NEW YORK UNIVERSITY (US) | 2026-01-01 | — | — | US | disclosed |
| US-12509502-B2 | Hybrid immunoglobulin containing nonpeptidyl linkage | BIOMOLECULAR HOLDINGS LLC (US) | 2025-12-30 | — | — | US | disclosed |
| EP-4656628-A1 | COMPOUND OR SALT THEREOF, LIPID COMPOSITION, PHARMACEUTICAL COMPOSITION, AND DELIVERY CARRIER | FUJIFILM Corporation (JP) | 2025-12-03 | — | — | EP | disclosed |
| US-20250345459-A1 | COMPOUND OR SALT THEREOF, LIPID COMPOSITION, PHARMACEUTICAL COMPOSITION, AND DELIVERY CARRIER | FUJIFILM CORPORATION (JP) | 2025-11-13 | — | — | US | disclosed |
| EP-4622673-A1 | NOVEL CARRIERS FOR NUCLEIC ACID AND/OR PROTEIN DELIVERY | Ludwig-Maximilians-Universität München (DE) | 2025-10-01 | — | — | EP | disclosed |
| EP-0774464-A2 | A template for solution phase synthesis of combinatorial libraries | Combichem, Inc. (US) | 1997-05-21 | — | — | EP | disclosed |
| EP-0751779-A1 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORPORATION (US) | 1997-01-08 | — | — | EP | disclosed |
| WO-1996017613-A1 | HEPATIC-DIRECTED COMPOUNDS AND REAGENTS FOR PREPARATION THEREOF | NEORX CORPORATION (US) | 1996-06-13 | — | — | WO | disclosed |
| US-5436221-A | Oligopeptides as antitumor agents | FUJI PHOTO FILM CO., LTD. (JP) | 1995-07-25 | — | — | US | disclosed |
| WO-1995001346-A1 | CHELATING COMPOUNDS | AKZO NOBEL N.V. (NL) | 1995-01-12 | — | — | WO | disclosed |
| WO-1995000165-A1 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORPORATION (US) | 1995-01-05 | — | — | WO | disclosed |
| EP-0619118-A1 | Use of peptide derivatives | FUJI PHOTO FILM CO., LTD. (JP) | 1994-10-12 | — | — | EP | disclosed |
| EP-0503301-A2 | Peptide derivatives and application thereof | FUJI PHOTO FILM CO., LTD. (JP) | 1992-09-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250345459-A1 | COMPOUND OR SALT THEREOF, LIPID COMPOSITION, PHARMACEUTICAL COMPOSITION, AND DELIVERY CARRIER | TLR9, NPC1L1, SLC10A1 | CA14 1830/4885HDAC6 563/4885HDAC1 330/4885 |
| US-20020048774-A1 | Liquid phase parallel synthesis of chemical libraries | CDK2, CDC25C, POLR2H | CA14 2806/4885HDAC6 3448/4885HDAC1 4516/4885 |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | CA14 38/4885HDAC6 532/4885HDAC1 611/4885 |
| US-20260108618-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | FCGR3B, FCGR1A, FCGR2A | CA14 853/4885HDAC6 1877/4885HDAC1 3732/4885 |
| US-12569565-B2 | Compositions and methods for the treatment of viral infections | ALB, FCGR3B, FCGR1A | CA14 589/4885HDAC6 1245/4885HDAC1 3289/4885 |
| US-20260001924-A1 | NEMO COILED COIL MIMICS AND METHODS OF USING SAME | DDX21, PHAX, RBX1 | CA14 4840/4885HDAC6 3152/4885HDAC1 2357/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | CA14 766/4885HDAC6 1429/4885HDAC1 250/4885 |
| US-12509502-B2 | Hybrid immunoglobulin containing nonpeptidyl linkage | FCGR2A, FCGR3B, CD74 | CA14 880/4885HDAC6 2411/4885HDAC1 3516/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.